EARLY-STAGE VC FIRM RAISES $450M, BUCKS AI MEGAFUND TREND
INDUSTRY DESK■ 1 MIN READ
TUE, MAY 12, 2026■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
A-Star, co-founded by Eventbrite's Kevin Hartz, announced a $450 million third fund on Tuesday—its largest yet, but a deliberate counterpoint to the multibillion-dollar AI investment vehicles gaining traction across venture capital.
Hartz and co-founder Bennett Siegel, formerly of Coatue, are charting a distinct path while competitors like Andreessen Horowitz deploy substantially larger funds to capture AI opportunities across company lifecycles.
The $450 million fund marks A-Star's most significant capital raise to date. The firm focuses on early-stage investments, a niche that contrasts sharply with the industry's recent pivot toward massive, AI-specialized vehicles designed to back startups at multiple growth phases.
Hartz, whose background spans founding Eventbrite and years as a startup investor, has observed the venture landscape shift toward larger check sizes and broader deployment strategies. A-Star's approach emphasizes concentrated bets during companies' initial growth stages.
The announcement underscores a widening divergence in venture strategy: while some firms chase AI ubiquity with megafunds, others remain committed to traditional early-stage thesis despite—or perhaps because of—sector trends toward consolidation around billion-dollar opportunities.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
19H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
19H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk